Validating the Spanish "Attitudes Toward Genomics and Precision Medicine" (AGPM).
What You Need to Know Before You Apply
What is the purpose of this trial?
The investigators aim to evaluate English and Spanish versions of the "Attitudes toward genomics and precision medicine" instrument (AGPM). This study will help validating a Spanish version of the AGPM among people identifying as Hispanic, Latino, or Latina. Having a valid instrument is important for developing tailored interventions to decrease disparities in genomic healthcare for this population.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What safety data exists for pharmacogenomics and precision medicine treatments?
The research does not provide specific safety data for the treatment itself, but it discusses the importance of understanding drug-gene interactions and the potential for adverse drug reactions (ADRs) in pharmacogenomics. This suggests that while pharmacogenomics can help tailor treatments to individuals, there is a need to be cautious about possible ADRs.12345
What data supports the effectiveness of the treatment Attitudes Toward Genomics and Precision Medicine (Spanish)?
The research indicates that healthcare professionals generally have positive attitudes toward precision medicine, which can help in making treatment decisions and providing prognostic information. However, there are concerns about costs, insurance, and knowledge gaps that need to be addressed for successful implementation.678910
Who Is on the Research Team?
Andrew A Dwyer, PhD
Principal Investigator
Boston College
Are You a Good Fit for This Trial?
This trial is for individuals identifying as Hispanic, Latino/a, or Latinx who have been diagnosed with Acute Lymphoblastic Leukemia. The study aims to include participants to validate a Spanish version of an attitudes survey on genomics and precision medicine.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Assessment
Participants complete the AGPM and other validated instruments to assess health literacy and numeracy
Follow-up
Participants are monitored for any additional data collection or feedback after the assessment
What Are the Treatments Tested in This Trial?
Interventions
- Attitudes Toward Genomics and Precision Medicine (Spanish)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston College
Lead Sponsor